Ethnic differences in polymorphisms of tumor necrosis factor-α, interleukin-10, and transforming growth factor-β1 genes in patients with chronic hepatitis C virus infection

American Journal of Tropical Medicine and Hygiene

Volumn 70, Issue 4, 2004, Pages 434-437

  Zein, Nizar N ^a   Germer, Jeffrey J ^b   El Zayadi, Abdel R ^c   Vidigal, Pedro G ^d  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

^c Cairo Liver Center   (Egypt)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; EGYPT; ETHNIC DIFFERENCE; FEMALE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE SEQUENCE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; VIRUS INFECTION;

HEPATITIS C VIRUS;

EID: 1942501220     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2004.70.434     Document Type: Article

References (21)

1. Howell C, Jeffers L, Hoofnagle JH, 2000. Hepatitis C in African Americans: Summary of a workshop. Gastroenterology 119: 1385-1396.
2. El-Serag HB, 2002. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 35 (Suppl 2): S72-S78.
3. Mallat DB, Jeffers L, 2002. The natural history of hepatitis C in African Americans. Am J Gastroenterol 97: 520-522.
4. Abel-Aziz F, Habib M, Mohamed MK, Abdel-Hamid M, Gamil F, Madkour S, Mikhail NN, Thomas D, Fix AD, Strickland GT, Anwar W, Sallam I, 2000. Hepatitis C infection in a community in the Nile Delta: Population description of HCV prevalence. Hepatology 32: 111-115.
5. Khan MH, Farrell GC, Byth K, Lin R, Weltman M, George J, Samarasinghe D, Kench J, Kaba S, Crewe E, Liddle C, 2000. Which patients with hepatitis C develop liver complications. Hepatology 31: 513-520.
6. el-Zayadi A, Simmonds P, Dabbous H, Prescott L, Selim O, Ahdy A, 1996. Response to interferon alpha of Egyptian patients infected with hepatitis C virus genotype 4. J Viral Hepat 3: 261-264.
7. Larrea E, Garcia N, Qian C, Civeira MP, Prieto J, 1996. Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C. Hepatology 23: 210-217.
8. Fukuda R, Ishimura N, Ishihara S, Chowdhury A, Morlyama N, Nogami C, Miyake T, Niigaki M, Tokuda A, Satoh S, Sakai S, Akagi S, Watanabe M, Fukomoto S, 1996. Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C. Liver 16: 390-399.
9. Osna N, Silonova G, Vilgert N, Hagina E, Kuse V, Giedraitis V, Zvirbliene A, Mauricas M, Sochnev A, 1997. Chronic hepatitis C: T-helper1/T-helper2 imbalance could cause virus persistence in peripheral blood. Scand J Clin Lab Invest 57: 703-710.
10. Tsushima H, Kawata S, Tamura S, Ito N, Shirai Y, Kiso S, Doi Y, Yamada A, Oshikawa O, Matsuzawa Y, 1999. Reduced plasma transforming growth factor-beta1 levels in patients with chronic hepatitis C after interferon-alpha therapy: association with regression of hepatic fibrosis. J Hepatol 30: 1-7.
11. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW, 1997. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94: 3195-3199.
12. Knight JC, Kwiatkowski D, 1999. Inherited variability of tumor necrosis factor production and susceptibility to infectious disease. Proc Assoc Am Physicians 111: 290-298.
13. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer zum Buschenfelde KH, Rittner C, 1998. Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection. J Med Virol 54: 173-177.
14. Hurme M, Lahdenpohja N, Santtila S, 1998. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med 30: 469-473.
15. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV, 1997. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24: 1-8.
16. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV, 1998. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66: 1014-1020.
17. Vidigal PG, Germer JJ, Zein NN, 2002. Polymorphisms in the interleukin-10, tumor necrosis factor-α, and transforming growth factor-β1 genes in chronic hepatitis C patients treated with interferon and ribavirin. J Hepatol 36: 271-277.
18. Brinkman BM, Huizinga TW, Kurban SS, van der Velde EA, Schreuder GM, Hazes JM, Breedveld FC, Verweij CL, 1997. Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol 36: 516-521.
19. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS, 1995. Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Comm 211: 833-839.
20. D'Alfonso S, Richiardi PM, 1994. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 39: 150-154.
21. Zimmerman PA, Guderian RH, Nutman TB, 1996. A new TNFA promoter allele identified in South American Blacks. Immunogenetics 44: 485-486.